openPR Logo
Press release

Investigation announced for Long Term Investors in shares of Assertio Holdings, Inc. (NASDAQ: ASRT) over potential Wrongdoing

An investigation on behalf of current long term investors in Assertio Holdings, Inc. (NASDAQ: ASRT) shares.

An investigation on behalf of current long term investors in Assertio Holdings, Inc. (NASDAQ: ASRT) shares.

An investigation was announced for long-term investors in shares of Assertio Holdings, Inc. (NASDAQ: ASRT) concerning potential breaches of fiduciary duties by certain directors and officers of Assertio Holdings, Inc.

Investors who are current long term investors in Assertio Holdings, Inc. (NASDAQ: ASRT) shares, have certain options and should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 - 1554.

The investigation by a law firm for current long term investors in NASDAQ: ASRT stocks follows a lawsuit filed against Assertio Holdings, Inc. over alleged securities laws violations. The investigation on behalf of current long term investors in NASDAQ: ASRT stocks, concerns whether certain Assertio Holdings, Inc. officers and directors are liable in connection with the allegations made in that lawsuit.

According to that complaint filed in the U.S. District Court for the Northern District of Illinois the plaintiff alleges that, the Defendants made false and/or misleading statements and/or failed to disclose thatthe Company's reliance on Indocin products to boost its net income was unsustainable given the risk of generic competition, that the Spectrum Acquisition was less valuable than Assertio had represented to investors, that accordingly, Assertio had overstated the positive impact the sale of Indocin products and the Spectrum Acquisition were likely to have on the Company's profitability, and that as a result, Defendants' public statements were materially false and/or misleading at all relevant times.

Those who purchased shares of Assertio Holdings, Inc. (NASDAQ: ASRT) have certain options and should contact the Shareholders Foundation.

Contact:
Michael Daniels
Shareholders Foundation, Inc.
3111 Camino Del Rio North
Suite 423
San Diego, CA 92108
Tel: +1-(858)-779-1554
E-Mail: mail@shareholdersfoundation.com

About Shareholders Foundation, Inc.
The Shareholders Foundation, Inc. is a professional portfolio monitoring and settlement claim filing service, and an investor advocacy group, which does research related to shareholder issues and informs investors of securities lawsuits, settlements, judgments, and other legal related news to the stock/financial market. Shareholders Foundation, Inc. is in contact with a large number of shareholders and offers help, support, and assistance for every shareholder. The Shareholders Foundation, Inc. is not a law firm. Referenced cases, investigations, and/or settlements are not filed/initiated/reached and/or are not related to Shareholders Foundation. The information is provided as a public service. It is not intended as legal advice and should not be relied upon.

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Investigation announced for Long Term Investors in shares of Assertio Holdings, Inc. (NASDAQ: ASRT) over potential Wrongdoing here

News-ID: 3551751 • Views:

More Releases from Shareholders Foundation, Inc.

Long-Term Investors in shares of Molina Healthcare, Inc. (NYSE: MOH) should contact the Shareholders Foundation in connection with potential Wrongdoing
Long-Term Investors in shares of Molina Healthcare, Inc. (NYSE: MOH) should cont …
An investigation on behalf of current long-term investors in shares of Molina Healthcare, Inc. (NYSE: MOH concerning potential breaches of fiduciary duties by certain directors and officers of Molina Healthcare, Inc. was announced. Investors who are current long term investors in Molina Healthcare, Inc. (NYSE: MOH) shares, have certain options and should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 - 1554. The investigation by a law
Cepton, Inc. (formerly NASDAQ: CPTN) Investor Alert: Investigation of potential Wrongdoing
Cepton, Inc. (formerly NASDAQ: CPTN) Investor Alert: Investigation of potential …
An investigation on behalf of investors in shares of Cepton, Inc. (formerly NASDAQ: CPTN) concerning potential breaches of fiduciary duties by certain directors and officers was announced. Investors who are current long term investors in Cepton, Inc. (formerly NASDAQ: CPTN) shares, have certain options and should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 - 1554. The investigation by a law firm for investors in formerly NASDAQ:
Investigation announced for long term investors in shares of Spirit Aviation Holdings, Inc. (OTC: FLYYQ) over potential Wrongdoing
Investigation announced for long term investors in shares of Spirit Aviation Hol …
An investigation was announced concerning potential breaches of fiduciary duties by certain directors and officers of Spirit Aviation Holdings, Inc. Investors who are current long term investors in Spirit Aviation Holdings, Inc. (OTC: FLYYQ) shares, have certain options and should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 - 1554. The investigation by a law firm for current long term investors in OTC: FLYYQ stocks follows a
ALERT: Lawsuit filed for Investors who lost money with shares of Bath & Body Works, Inc. (NYSE: BBWI)
ALERT: Lawsuit filed for Investors who lost money with shares of Bath & Body Wor …
An investor, who purchased shares of Bath & Body Works, Inc. (NYSE: BBWI), filed a lawsuit over alleged violations of Federal Securities Laws by Bath & Body Works, Inc. Investors who purchased shares of Bath & Body Works, Inc. (NYSE: BBWI) have certain options and for certain investors are short and strict deadlines running. Deadline: March 16, 2026. NYSE: BBWI investors should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call

All 5 Releases


More Releases for Assertio

Analgesics Market - Major Technology Giants in Buzz Again | AbbVie, Bayer, Janss …
Archive Market Research published a new research publication on "Global Analgesics Market Insights, to 2030" with 232 pages and enriched with self-explained Tables and charts in presentable format. In the Study, you will find new evolving Trends, Drivers, Restraints, Opportunities generated by targeting market-associated stakeholders. The growth of the Analgesics market was mainly driven by the increasing R&D spending across the world. Get Free Exclusive PDF Sample Copy of This Research
Lawsuit filed for Investors who lost money with shares of Assertio Holdings, Inc …
An investor, who purchased shares of Assertio Holdings, Inc. (NASDAQ: ASRT), filed a lawsuit over alleged violations of Federal Securities Laws by Assertio Holdings, Inc. in connection with certain allegedly false and misleading statements. Investors who purchased shares of Assertio Holdings, Inc. (NASDAQ: ASRT) have certain options and for certain investors are short and strict deadlines running. Deadline: March 5, 2024. NASDAQ: ASRT investors should contact the Shareholders Foundation at mail@shareholdersfoundation.com
Conventional and Alternative Pain Treatment Market Trend And Growth Opportunitie …
The report named, *Global Conventional and Alternative Pain Treatment Market Research Report 2022* has been added to the archive of market research studies by QY Research. The industry experts and researchers have offered a reliable and precise analysis of the global Conventional and Alternative Pain Treatment market in view of numerous aspects such as growth factors, challenges, limitations, developments, trends, growth opportunities, geographical expansion, market segments, competitive landscape, manufacturing, and
Gabapentin Market 2021 Precise Outlook – Pfizer, Assertio Therapeutics, TEVA, …
The Global Gabapentin Market Research Report 2021-2027 is a valuable source of insightful data for business strategists. It provides the industry overview with growth analysis and historical & futuristic cost, revenue, demand, and supply data (as applicable). The research analysts provide an elaborate description of the value chain and its distributor analysis. This Market study provides comprehensive data which enhances the understanding, scope, and application of this report. In 2020, the
Gabapentin Market Trend and Growth Opportunities by 2027| Pfizer, Assertio Thera …
QY Research has Published Latest Trending Report on Global Gabapentin Market  Los Angeles, United State, – The report titled Gabapentin Market is one of the most comprehensive and important additions to QY Research’s archive of market research studies. It offers detailed research and analysis of key aspects of the global Gabapentin market. The market analysts authoring this report have provided in-depth information on leading growth drivers, restraints, challenges, trends, and opportunities to offer a
Gabapentin Market Trends Analysis, Top Manufacturers, Shares, Growth Opportuniti …
The global Gabapentin market is carefully researched in the report while largely concentrating on top players and their business tactics, geographical expansion, market segments, competitive landscape, manufacturing, and pricing and cost structures. Each section of the research study is specially prepared to explore key aspects of the global Gabapentin market. For instance, the market dynamics section digs deep into the drivers, restraints, trends, and opportunities of the global Gabapentin Market.